Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 16, 2021

SELL
$23.37 - $32.13 $192,545 - $264,719
-8,239 Closed
0 $0
Q2 2021

Aug 11, 2021

BUY
$18.78 - $25.15 $154,728 - $207,210
8,239 New
8,239 $202,000
Q2 2020

Aug 04, 2020

SELL
$13.31 - $19.41 $166,747 - $243,168
-12,528 Closed
0 $0
Q1 2020

May 06, 2020

BUY
$13.06 - $21.24 $163,615 - $266,094
12,528 New
12,528 $181,000

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.51B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Quantitative Systematic Strategies LLC Portfolio

Follow Quantitative Systematic Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.